549 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

ALX Oncology Competitors or Alternatives

ALX Oncology's top competitors include Precigen, Zymeworks and Numab.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

ALX Oncology's company profile

Jason Lettmann

CEO

82/100
40
$706.6M
$1.2M
  • $706.6M
    $1.2M
  • 40
    $706.6M
  • $1.2M
  • 82/100
  • 40
  • $706.6M
  • $1.2M
View ProfileView
1
ALX Oncology's Competitor - Precigen logo

Helen Sabzevari

President & CEO

90/100
190
$1.1B
$3.9M
  • $1.1B
    $3.9M
  • 190
    $1.1B
  • $3.9M
  • 90/100
  • 190
  • $1.1B
  • $3.9M
View ProfileView
2
ALX Oncology's Competitor - Zymeworks logo

Kenneth Galbraith

Chairman & CEO

88/100
277
$1.2B
$50.5M
  • $1.2B
    $50.5M
  • 277
    $1.2B
  • $50.5M
  • 88/100
  • 277
  • $1.2B
  • $50.5M
View ProfileView
3
ALX Oncology's Competitor - Numab logo

David Urech

Co-Founder & CEO

89/100
25 - 100
$204M
$5M - 25M
  • $204M
    $5M - 25M
  • 25 - 100
    $204M
  • $5M - 25M
  • 89/100
  • 25 - 100
  • $204M
  • $5M - 25M
View ProfileView
ALX Oncology's top 3 competitors are Precigen, Zymeworks and Numab. Together they have raised over 2.5B between their estimated 522 employees. ALX Oncology has 40 employees and is ranked 4th among it's top 10 competitors. The top 10 competitors average 140.

ALX Oncology VS Precigen

Precigen is seen as one of ALX Oncology's top competitors. Precigen was founded in 1998, and is headquartered in Germantown, Maryland. Like ALX Oncology, Precigen also competes in the Biotechnology industry. Precigen generates $2.7M more revenue vs. ALX Oncology.

ALX Oncology VS Zymeworks

Zymeworks is a top competitor of ALX Oncology. Zymeworks was founded in 2003, and its headquarters is in Vancouver, British Columbia. Like ALX Oncology, Zymeworks also competes in the Biotechnology field. Zymeworks has 237 more employees than ALX Oncology.

ALX Oncology VS Numab

Numab is ALX Oncology's #3 rival. Numab was founded in Horgen, Zurich} in 2011. Like ALX Oncology, Numab also works within the Biotechnology industry. Compared to ALX Oncology, Numab generates $15.4M more revenue.

Looking for similar companies to ALX Oncology?

Similar Companies

Biotechnology companies in San Francisco

See 326 companies 
Biotechnology companies in San Francisco Bay Area

See 1,319 companies 
Pharmaceuticals & Biotechnology companies in San Francisco

See 386 companies 
Pharmaceuticals & Biotechnology companies in San Francisco Bay Area

See 1,673 companies 
Biotechnology companies in California

See 3,096 companies 
Pharmaceuticals & Biotechnology companies in California

See 4,181 companies 
Biotechnology companies with revenue in $100K-5.0M range

See 4,537 companies 
Biotechnology companies with employees in 25-100 range

See 5,169 companies 
Pharmaceuticals & Biotechnology companies with revenue in $100K-5.0M range

See 6,045 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for ALX Oncology and ALX Oncology's Competitors

April 16, 2025StreetInsider
International event will raise awareness and bring together RRP patients, caregivers, and the healthcare community supporting them Recurrent respirator...

Frequently Asked Questions about ALX Oncology

  1. Who are ALX Oncology's top competitors?

    ALX Oncology's top 3 competitors are Precigen, Zymeworks, Numab.

  2. Who is similar to ALX Oncology?

    Precigen is the most similar to ALX Oncology. Zymeworks and Numab are also similar to ALX Oncology.

  1. Are ALX Oncology and Precigen competitors?

    Yes, Precigen is one of ALX Oncology’s top competitors.